Brief: Sutro Biopharma Q2 Revenue USD 10.412 Million Vs. IBES Estimate USD 12.6 Million
10/08/2023 21:30
Aug 10 (Reuters) - Sutro Biopharma Q2 operating income USD -46.179 million. * Q2 net income USD -38.524 million * Q2 operating expenses USD 56.591 million * Q2 basic EPS USD -0.64
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates